Production (Stage)
MediciNova, Inc.
MNOV
$1.41
$0.01991.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.36M | 1.28M | 1.45M | 1.40M | 1.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.20M | 3.18M | 3.31M | 3.05M | 3.14M |
| Operating Income | -3.20M | -3.18M | -3.31M | -3.05M | -3.14M |
| Income Before Tax | -2.86M | -2.81M | -2.85M | -2.63M | -2.75M |
| Income Tax Expenses | -- | 5.50K | -- | -- | -- |
| Earnings from Continuing Operations | -2.86M | -2.81M | -2.85M | -2.63M | -2.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.86M | -2.81M | -2.85M | -2.63M | -2.75M |
| EBIT | -3.20M | -3.18M | -3.31M | -3.05M | -3.14M |
| EBITDA | -3.20M | -3.18M | -3.30M | -3.04M | -3.13M |
| EPS Basic | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.04 | -0.03 | -0.04 |
| EPS Diluted | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.04 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M |
| Average Diluted Shares Outstanding | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |